Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Mydecine Innovations Group Inc

MYCOF
Current price
0.0042 USD -0.0012 USD (-22.22%)
Last closed 0.01 CAD
ISIN unknown
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange CN
Capitalization 619 749 CAD
Yield for 12 month -94.44 %
1Y
3Y
5Y
10Y
15Y
MYCOF
21.11.2021 - 28.11.2021

Mydecine Innovations Group Inc., a biotechnology company, engages in the research, development, and commercialization of psilocybin products to treat mental health conditions. The company primarily focuses on treating nicotine addiction and post-traumatic stress disorder. Its lead product drug candidates include MYCO-005. The company also develops MYCO-006 and MYCO-007. Mydecine Innovations Group Inc. has a partnership with Applied Pharmaceutical Innovation for pharmaceutical drug discovery, research, and development on empathogenic and entactogenic compounds. The company was formerly known as NewLeaf Brands Inc. and changed its name to Mydecine Innovations Group Inc. in June 2020. Mydecine Innovations Group Inc. was incorporated in 2013 and is headquartered in Vancouver, Canada. Address: 1075 West Georgia Street, Vancouver, BC, Canada, V6E 3C9

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

P/E ratio

Dividend Yield

Current Year

Last Year

+7 520 CAD

Current Quarter

Last Quarter

Current Year

Last Year

Current Quarter

Last Quarter

Key Figures MYCOF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -6 251 414 CAD
Operating Margin TTM
PE Ratio
Return On Assets TTM -658.44 %
PEG Ratio
Return On Equity TTM -95.12 %
Wall Street Target Price
Revenue TTM 263 048 CAD
Book Value -0.25 CAD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -26.9 %
Dividend Yield
Gross Profit TTM 183 373 CAD
Earnings per share -0.15 CAD
Diluted Eps TTM -0.15 CAD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics MYCOF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History MYCOF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:50
Payout Ratio
Last Split Date 21.04.2022
Dividend Date

Stock Valuation MYCOF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1762.9247
Price Sales TTM 567.1698
Enterprise Value EBITDA -0.5609
Price Book MRQ 6.2125

Financials MYCOF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators MYCOF

For 52 weeks

0.005 CAD 0.2 CAD
50 Day MA 0.014 CAD
Shares Short Prior Month 2 672
200 Day MA 0.022 CAD
Short Ratio 0.09
Shares Short 9 411
Short Percent